ENTACAPONE News

← Back to News Overview

---

ENTACAPONE currently has 0 news articles, with 18 predicted indications.

This page combines the AI-predicted indications for ENTACAPONE with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

• Evidence level: L5
• Predicted indications (18):
  • hereditary late onset Parkinson disease (99.0%)
  • early-onset parkinsonism-intellectual disability syndrome (99.0%)
  • juvenile onset Parkinson disease 19A (99.0%)
  • X-linked parkinsonism-spasticity syndrome (99.0%)
  • parkinsonian-pyramidal syndrome (99.0%)
  • Parkinson disease (99.0%)
  • atypical juvenile parkinsonism (99.0%)
  • hemiparkinsonism-hemiatrophy syndrome (99.0%)
  • PLA2G6-associated neurodegeneration (99.8%)
  • Rasmussen subacute encephalitis (99.7%)
  • myelitis (99.6%)
  • paralysis agitans, juvenile, of Hunt (99.6%)
  • transaldolase deficiency (99.4%)
  • lethal infantile mitochondrial myopathy (99.3%)
  • Lewy body dementia (99.2%)
  • fructose-1,6-bisphosphatase deficiency (99.2%)
  • polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis (99.1%)
  • progressive supranuclear palsy-corticobasal syndrome (99.0%)

View full drug report →

Related News (0)

No related news yet. When news mentions this drug, it will be collected and shown here automatically.

Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.